Prospects for worldwide tuberculosis control under the WHO DOTS strategy

Lancet

Volumn 352, Issue 9144, 1998, Pages 1886-1891

  Dye, Christopher ^a   Garnett, Geoffrey P ^b   Sleeman, Karen ^b   Williams, Brian G ^c  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b Ctr for the Epidemiol of I   (United Kingdom)

^c Epidemiology Research Unit   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ARTICLE; ENDEMIC DISEASE; EPIDEMIC; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MORTALITY; PRIORITY JOURNAL; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

EID: 0032512283     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)03199-7     Document Type: Article

References (24)

1. 1 Fox W, Mitchison DA. Short-course chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis 1975; 111: 325-53.
2. 2 Iseman MD, Cohen DL, Sbarbaro JA. Directly observed treatment of tuberculosis. We can't afford not to do it. N Engl J Med 1993; 328: 576-78.
3. 3 Bayer R, Wilkinson D. Directly observed therapy for tuberculosis: history of an idea. Lancet 1995; 345: 1545-48.
4. 4 Rieder H. Case finding. In: Reichman LB, Hershfield ES, eds. Tuberculosis: a comprehensive international approach. New York: Marcel Dekker Inc, 1993: 167-82.
5. 5 Styblo K. Epidemiology of tuberculosis. The Hague: KNCV, Royal Netherlands Tuberculosis Association, 1991.
6. 6 O'Brien RJ. Preventive therapy for tuberculosis. In: Porter JDH, McAdam KPWJ, eds. Tuberculosis: back to the future. Chichester: John Wiley & Sons, 1994: 151-65.
7. 7 WHO. Framework for effective tuberculosis control. Geneva: WHO, 1994: WHO/TB/94.17.
8. 8 Raviglione MC, Dye C, Schmidt S, Kochi A, for the Global Surveillance and Monitoring Project. Assessment of worldwide tuberculosis control. Lancet 1997; 350: 624-29.
9. 9 Blower S, Small P, Hopewell P. Control strategies for tuberculosis epidemics: new models for old problems. Science 1996; 273: 497-500.
10. 10 Vynnycky E. An investigation of the transmission dynamics of M tuberculosis. PhD thesis. London: University of London, 1996.
11. 11 Vynnycky E, Fine PEM. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect 1997; 119: 183-201.
12. 12 Garnett G, Anderson R. Balancing sexual partnerships in an age and activity stratified model of HIV transmission in heterosexual populations. IMA Math Appl Med Biol 1994; 11: 161-92.
13. 13 WHO. Global tuberculosis control. WHO report 1998. Geneva, WHO, 1998: WHO/TB/98-237.
14. 14 Cauthen G, Pio A, ten Dam H. Annual risk of tuberculosis infection. Geneva: WHO, 1998: WHO/TB/88.154.
15. 15 Murray C, Styblo K, Rouillon A. Tuberculosis. In: Jamison DT, Mosley WH, Feachem R, eds. Disease control priorities in developing countries. Oxford: Oxford University Press, 1993: 233-59.
16. 16 UNAIDS/WHO. Report on the global HIV/AIDS epidemic, December, 1997. Geneva: WHO, 1997: UNAIDS/WHO 1997.
17. 17 United Nations Population Division. World population prospects, 1996 revision. Geneva: UNPD, 1996.
18. 18 Blower SM, Dowlatabadi H. Sensitivity and uncertainty analysis of complex disease models: an HIV model, as an example. Int Stat Rev 1994; 62: 229-43.
19. 19 Comstock GW, Cauthen GM. Epidemiology of tuberculosis. In: Reichman LB, Hershfield ES, eds. Tuberculosis: a comprehensive international approach. New York: Marcel Dekker Inc, 1993: 23-48.
20. 20 Styblo K, Bumgarner R. Tuberculosis can be controlled with existing technologies: evidence. Tubercul Surveill Res Unit Progress Report 1991; 2: 60-72.
21. 21 Harries AD. Tuberculosis in Africa: clinical presentation and management. Pharmacol Therapeut 1997; 73: 1-50.
22. 22 Raviglione MC, Harries AD, Msiska R, Wilkinson D, Nunn P. Tuberculosis and HIV: current status in Africa. AIDS 1997; 11: S115-23.
23. 23 WHO. The continually changing threat of infectious diseases. In: Investing in health research and development. Geneva: WHO, 1996: 35-53.
24. 24 WHO/International Union Against Tuberculosis and Lung Disease. Anti-tuberculosis drug resistance in the world. Geneva: WHO, 1997: WHO/TB/97.229.